| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |